Truist Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Truist Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,669	Closed	-$527K	–	2477
2020 Q2	$527K	Sell	2,669 -81	-3%	-$16.8K	﹤0.01%	1593
2020 Q1	$538K	Buy	2,750 +28	+1%	+$6.03K	﹤0.01%	1523
2019 Q4	$563K	Buy	+2,722	New	+$503K	﹤0.01%	1767

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Truist Financial's LKFT Position: Q3 2020 in Review

Truist Financial sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 2,669 shares — an estimated $527K sold.

Truist Financial first reported a position in LKFT in Q4 2019 and held it in 3 quarters. The position peaked at $563K in Q4 2019. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Truist Financial reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Truist Financial sold 2,669 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $527K.
Truist Financial first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 3 quarters.
Truist Financial's Lakefront Biotherapeutics American Depositary Shares position peaked at $563K in Q4 2019.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Truist Financial's 13F filing for Q3 2020, filed 13 Nov 2020.